|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||244.96 - 244.96|
|52-week range||244.96 - 244.96|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||12.54|
|Earnings date||04 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Anyone positioning their portfolio for a recession could be making a big mistake.
In this article we are going to estimate the intrinsic value of Eli Lilly and Company ( NYSE:LLY ) by taking the...
Yahoo Finance senior health reporter Anjalee Khemlani details Eli Lilly's type-2 diabetes drug approval by the FDA for use as a weight loss drug.